WST250117P200000
- 2.25
- 0.000.00%
West Pharmaceutical Services Newsroom
Is It Too Late To Consider Buying West Pharmaceutical Services, Inc. (NYSE:WST)?
West Pharmaceutical Services (NYSE:WST) Shareholders Have Earned a 17% CAGR Over the Last Five Years
Looking Into West Pharmaceutical Servs's Recent Short Interest
Deutsche Bank Adjusts West Pharmaceutical Services Price Target to $305 From $265
How Is West Pharmaceutical Services' Stock Performance Compared to Other Medical Devices Stocks?
West Pharmaceutical Services Re-Authorizes Stock Buybacks for 2025
West Pharma Is Maintained at Buy by B of A Securities
Express News | West Pharmaceutical Services Inc : BofA Global Research Raises Price Objective to $355 From $350
West Pharma Initiated at Peer Perform by Wolfe Research
BofA Securities Maintains West Pharmaceutical Services(WST.US) With Buy Rating, Announces Target Price $355
Wolfe Research Initiates West Pharmaceutical Services(WST.US) With Hold Rating
West Pharmaceutical Services Shares Are Trading Higher After UBS Upgraded the Stock From Neutral to Buy and Raised Its Price Target From $350 to $390.
West Pharma Raised to Buy From Neutral by UBS
West Pharmaceutical Servs Analyst Ratings
UBS Initiates West Pharmaceutical Services(WST.US) With Buy Rating, Announces Target Price $390
Express News | West Pharmaceutical Services Inc - Board Now Has 12 Directors
Express News | West Elects New Director to the Board
Press Release: West Elects New Director to the Board
Wells Fargo's 'SMID-cap' List: TKO, BRBR, CPAY, and More!
Is West Pharmaceutical Services, Inc. (NYSE:WST) Expensive For A Reason? A Look At Its Intrinsic Value